The bone remodeling environment is a factor in breast cancer bone metastasis
- PMID: 20472107
- DOI: 10.1016/j.bone.2010.05.007
The bone remodeling environment is a factor in breast cancer bone metastasis
Abstract
The bone microenvironment is clearly an important determinant of breast cancer metastasis to bone. Once established in bone, the ability for breast cancer cells to hijack normal regulatory pathways for osteoclast differentiation, activation, and survival is known to form the basis of a vicious cycle that promotes both bone destruction and tumor growth. However, the importance of the background remodeling activity in the early stages of breast cancer metastatic establishment in bone has not been systematically investigated. Here we review recent studies that indicate that bone remodeling levels, as influenced by calcium and vitamin D status, do impact the ability of human breast cancer cells to grow in the bones of nude mice. These studies support the assessment and correction of calcium and vitamin D deficient states in women at risk of developing advanced breast cancer.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis.Bone. 2010 Oct;47(4):795-803. doi: 10.1016/j.bone.2010.07.012. Epub 2010 Jul 16. Bone. 2010. PMID: 20638491
-
Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.Cancer Res. 1995 Aug 15;55(16):3551-7. Cancer Res. 1995. PMID: 7627963
-
E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.Cancer Res. 1996 Sep 1;56(17):4063-70. Cancer Res. 1996. PMID: 8752180
-
Examining the metastatic niche: targeting the microenvironment.Semin Oncol. 2010 Oct;37 Suppl 2:S2-14. doi: 10.1053/j.seminoncol.2010.10.007. Semin Oncol. 2010. PMID: 21111245 Review.
-
Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.Bone. 2011 Jan;48(1):6-15. doi: 10.1016/j.bone.2010.07.015. Epub 2010 Jul 17. Bone. 2011. PMID: 20643235 Review.
Cited by
-
A tissue-engineered humanized xenograft model of human breast cancer metastasis to bone.Dis Model Mech. 2014 Feb;7(2):299-309. doi: 10.1242/dmm.014076. Dis Model Mech. 2014. PMID: 24713276 Free PMC article.
-
Clinicopathological characteristics and prognostic risk factors of breast cancer patients with bone metastasis.Ann Transl Med. 2021 Aug;9(16):1340. doi: 10.21037/atm-21-4052. Ann Transl Med. 2021. PMID: 34532477 Free PMC article.
-
CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone.Am J Pathol. 2011 May;178(5):2377-88. doi: 10.1016/j.ajpath.2011.01.033. Am J Pathol. 2011. PMID: 21514448 Free PMC article.
-
The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancer.BMC Cancer. 2015 Jul 10;15:512. doi: 10.1186/s12885-015-1528-y. BMC Cancer. 2015. PMID: 26156521 Free PMC article.
-
Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis.Clin Exp Metastasis. 2013 Mar;30(3):317-32. doi: 10.1007/s10585-012-9539-4. Epub 2012 Sep 30. Clin Exp Metastasis. 2013. PMID: 23053744
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical